Literature DB >> 20403723

Xerostomia in head and neck malignancy.

S R Porter1, S Fedele, K M Habbab.   

Abstract

Xerostomia (dry mouth) as a consequence of treatment of head and neck malignancy is almost always due to radiotherapy. The resultant salivary gland dysfunction can adversely affect oral and systemic health as well as lessen quality of life. While the present management of radiotherapy-associated salivary dysfunction is challenging there have been striking advances in preventative strategies and a number of possible treatment options may be over the near horizon. Copyright 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20403723     DOI: 10.1016/j.oraloncology.2010.03.008

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  10 in total

1.  Parotid gland-recovery after radiotherapy in the head and neck region--36 months follow-up of a prospective clinical study.

Authors:  Jeremias Hey; Juergen Setz; Reinhard Gerlach; Martin Janich; Guido Hildebrandt; Dirk Vordermark; Christian R Gernhardt; Thomas Kuhnt
Journal:  Radiat Oncol       Date:  2011-09-27       Impact factor: 3.481

2.  Anti-caries effect of CPP-ACP in irradiated nasopharyngeal carcinoma patients.

Authors:  Christina P C Sim; Joseph Wee; Ying Xu; Yin-Bun Cheung; Yoke-Lim Soong; David J Manton
Journal:  Clin Oral Investig       Date:  2014-09-27       Impact factor: 3.573

Review 3.  Appropriate and necessary oral care for people with cancer: guidance to obtain the right oral and dental care at the right time.

Authors:  Joel B Epstein; Pelin Güneri; Andrei Barasch
Journal:  Support Care Cancer       Date:  2014-03-28       Impact factor: 3.603

4.  Radioprotective effects and mechanism of HL-003 on radiation-induced salivary gland damage in mice.

Authors:  Jingming Ren; Rong Huang; Yanjie Li; Ruiyang Chen; Hongqi Tian; Chenlu Liu
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

5.  The Long-Term Recovery of Parotid Glands in Nasopharyngeal Carcinoma Treated by Intensity-Modulated Radiotherapy.

Authors:  Shun Tasaka; Keiichi Jingu; Noriyoshi Takahashi; Rei Umezawa; Takaya Yamamoto; Yojiro Ishikawa; Kazuya Takeda; Yu Suzuki; Noriyuki Kadoya
Journal:  Front Oncol       Date:  2021-05-07       Impact factor: 6.244

Review 6.  Interventions for the management of dry mouth: non-pharmacological interventions.

Authors:  Susan Furness; Gemma Bryan; Roddy McMillan; Sarah Birchenough; Helen V Worthington
Journal:  Cochrane Database Syst Rev       Date:  2013-09-05

7.  Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomia.

Authors:  Joel Castelli; Antoine Simon; Guillaume Louvel; Olivier Henry; Enrique Chajon; Mohamed Nassef; Pascal Haigron; Guillaume Cazoulat; Juan David Ospina; Franck Jegoux; Karen Benezery; Renaud de Crevoisier
Journal:  Radiat Oncol       Date:  2015-01-09       Impact factor: 3.481

8.  Research Value of Intensity Modulated Radiation Therapy in Alleviating Parotid Gland Function Injury in Patients with Stage N0 Nasopharyngeal Carcinoma from Physical and Dosimetric Aspects.

Authors:  Lirong Zheng; Hong Wang; Neng Yang; Fenglei Du; Lin Xiao; Gangfeng Wu
Journal:  Comput Math Methods Med       Date:  2022-07-11       Impact factor: 2.809

9.  Xerostomia after Radiotherapy for Oral and Oropharyngeal Cancer: Increasing Salivary Flow with Tasteless Sugar-free Chewing Gum.

Authors:  Julie Killerup Kaae; Lone Stenfeldt; Jesper Grau Eriksen
Journal:  Front Oncol       Date:  2016-05-03       Impact factor: 6.244

10.  Protective effects of alpha lipoic acid on radiation-induced salivary gland injury in rats.

Authors:  Jin Hyun Kim; Kyung Mi Kim; Myeong Hee Jung; Jung Hwa Jung; Ki Mun Kang; Bae Kwon Jeong; Jin Pyeong Kim; Jung Je Park; Seung Hoon Woo
Journal:  Oncotarget       Date:  2016-05-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.